Metabolic · Mitochondrial · Cardiolipin

EnergyGuardSS-31

Mitochondrial peptide (cardiolipin) · the first FDA-approved drug that acts on the mitochondria

The ReferenceBenefits, protocols and preparationOpen the reference →
Purity
≥99%
Format
20mg
Origin
Mitochondrial
Target
Cardiolipin
Molecule approved in United States · 2025 · orphan designation in European UnionWhat this means ›
🇺🇸 United States · Approved🇪🇺 European Union · Orphan designation

The molecule is approved as a medicine in United States, under the brand Forzinity. It holds orphan drug designation in European Union. In September 2025 the FDA granted accelerated approval to elamipretide (SS-31) under the brand Forzinity, to improve muscle strength in Barth syndrome. It is the first mitochondria-targeted therapy ever approved. In the European Union it has held orphan designation for the same disease since 2021, with no marketing authorisation yet.

Accelerated approval for one specific rare disease. What is approved is the molecule under that brand; our vial is research material (RUO).

Source: FDA · Forzinity (elamipretida), 19-sep-2025 · EMA · designación huérfana (jun 2021)

For research use only (RUO) Ships from Quito · EC 1-3 days · LATAM 4-10 Arrives damaged? We replace it free COA per batch
CAS · 736992-21-5 Class · Tetrapeptide Stock · Available
How it works

4 mechanisms. Repairs the power plant.

SS-31 (Elamipretide) is a tetrapeptide that concentrates in the inner mitochondrial membrane and binds cardiolipin. It doesn't stimulate: it stabilizes and repairs.

Binds cardiolipin

Concentrates in the inner mitochondrial membrane and associates with cardiolipin, the phospholipid that organizes the cristae.

More ATP

By stabilizing the cristae it improves the efficiency of the respiratory chain, associated with greater ATP production.

Less oxidative stress

Reduces electron leak and reactive-species generation, protecting the mitochondria from damage.

Repairs, doesn't stimulate

Unlike agonists, it doesn't force signaling: it restores the structure of the cell's "power plant."

Why combine it

Longevity & deep anti-aging

See all combinations in the Consultation →
The compound

Technical description.

SS-31 (also known as Elamipretide) is a mitochondrial tetrapeptide that concentrates in the inner mitochondrial membrane and binds cardiolipin, the phospholipid that organizes the cristae where energy is produced. By stabilizing that structure, it is associated with more ATP and less oxidative stress: it repairs the cell's "power plant" rather than stimulating it.

SuperBio Labs SS-31 is supplied as lyophilized powder with verified HPLC ≥99% purity. Each lot ships with an independent Certificate of Analysis confirming identity by LC-MS, peptide content (98–102%), and endotoxin levels (<1.0 EU/mg).

It is the mitochondrial peptide with the strongest clinical evidence: in September 2025 the FDA granted it accelerated approval (brand Forzinity) to improve muscle strength in Barth syndrome, the first approved drug that acts directly on the mitochondria. In phase 2 it slowed photoreceptor loss by 43% in dry macular degeneration (without meeting the primary endpoint), and in phase 2a it protected the kidney when blood flow through a renal artery was restored. In adult mitochondrial myopathy (phase 3) it did not improve walking or fatigue, and in heart failure the signals are mixed. For energy and anti-aging in healthy people, its use is a reasonable extrapolation from that data, not yet proven. It has no support for weight, gut, skin, sleep or libido.

Informed professional research use only.

Complete kit · ready to reconstitute.

Each order includes everything needed to use the full vial. No separate purchases required.

Vial + BWFI + syringes + alcohol swabs · kit contents
1× lyophilized SS-31 20mg vial
1× 3 ml BWFI vial (bacteriostatic water)
insulin syringes U-100 0.5ml 29G
alcohol wipes 70%
1× cycle organizer box
1× printed reconstitution guide
1× application protocol
1× batch COA (digital + printed)
Before you buy · from any store

How to choose where to buy peptides.

01
Per-batch, verifiable COA The certificate exists and can be checked — not "available on request".
→
02
HPLC purity + LC-MS identity How much is in the vial, and that it is the right peptide.
→
03
Endotoxins tested LAL test within range — not just purity.
→
04
2-8°C cold chain Documented end to end, not promised.
→
05
Traceability and support Lot number on the vial and someone who answers after.

This product meets all five — your batch COA ships with the kit.

Recommended application protocol.

The official protocol included in the kit. If you have a cardiac condition or take medication, consult your physician before starting.

Reconstitution
2 ml of bacteriostatic water → 10 mg/ml
Standard dose
1 mg
U-100 units
10 u
Frequency
5×/week · same time each day
Best timing
Same time each day · rotate injection site
Cycle length
8 weeks ON / 4 weeks OFF
Combine with
MOTS-c (alternate), NAD+, BPC-157
Storage (reconstituted)
60 days refrigerated (2–8°C)

When to use SS-31.

Cellular energy

Declining mitochondrial function · fatigue · documented primary objective.

Longevity

Mitochondrial protection against oxidative damage · biohacker protocol.

Recovery

High training-load phases · recovery support alongside BPC-157.

Performance

Muscular oxidative capacity · secondary objective (not anabolic).

Mito-stack

Structural piece alongside MOTS-c (signal) and NAD+ (cofactor), alternating.

Cardiac function

Phase 2 signals in heart failure, in clinical research · tissue with high mitochondrial demand.

Muscle with age

Fatigue and loss of muscular endurance with age: restored ATP in aged muscle (preclinical).

Eyes and retina

Retinal aging: in phase 2 it slowed photoreceptor loss in dry macular degeneration.

Kidney

Kidney under low-flow stress: in phase 2a it protected the kidney when circulation was restored.

Honest side effects.

Benign in trials. In the research literature the profile is favorable:

Local reaction at the injection site (most common) · better tolerated than NAD+ because it doesn't cause flushing · no significant systemic effects reported in the available studies. Much of the evidence comes from clinical populations (Barth syndrome, dry AMD); use in healthy people for energy/anti-aging is a reasonable extrapolation, not yet proven.

Technical specifications

Also known asElamipretide
CAS number736992-21-5
ClassMitochondrial tetrapeptide
Molecular targetCardiolipin (inner mitochondrial membrane)
Purity (HPLC)≥99%
FormatLyophilized powder
Quantity20 mg per vial
Endotoxins<1.0 EU/mg
Storage−20 °C, protected from light
UseUse under professional judgment

Also in Metabolic